MAHA Must Prepare for the Future of Medicine
This week, the Food and Drug Administration reviewed whether certain peptide therapies should be more widely available through compounding pharmacies. Some of the top names in…
Written byJarrett StepmanSource: The Daily Signal
This week, the Food and Drug Administration reviewed whether certain peptide therapies should be more widely available through compounding pharmacies. Some of the top names in longevity and health—including Brigham Buhler and Gary Brecka—arrived in Washington to weigh in on the latest Make America Healthy Again hot-button issue, raising questions about safety, innovation, and access....

